Caroline D. Dorsa's Insider Trades & SAST Disclosures
Caroline D. Dorsa's most recent trade in Biogen Inc was a trade of 1,235 Common Stock done at an average price of $122.7 . Disclosure was reported to the exchange on May 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Caroline D. Dorsa.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Inc | Caroline D. Dorsa | Director | Purchase of securities on an exchange or from another person at price $ 122.72 per share. | 02 May 2025 | 1,235 | 27,842 (0%) | 0% | 122.7 | 151,559 | Common Stock |
| Duke Energy Corp. | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 121.33 per share. | 01 May 2025 | 1,607 | 11,121 (0%) | 0% | 121.3 | 194,977 | Common Stock |
| Biogen Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,785 | 26,607 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 2,622 | 12,431 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.01 per share. | 15 May 2024 | 612 | 9,809 (0%) | 0% | 115.0 | 70,386 | Common Stock |
| Duke Energy Corp. | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 103.06 per share. | 09 May 2024 | 1,698 | 9,514 (0%) | 0% | 103.1 | 175,000 | Common Stock |
| Biogen Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 1,580 | 24,822 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,532 | 10,421 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.65 per share. | 24 May 2023 | 492 | 8,889 (0%) | 0% | 212.7 | 104,624 | Common Stock |
| Duke Energy Corp. | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 98.15 per share. | 04 May 2023 | 1,783 | 7,816 (0%) | 0% | 98.1 | 175,000 | Common Stock |
| Biogen Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 23,242 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 7,688 | 7,688 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 5,197 | 12,701 (0%) | 0% | 0 | Common Stock | |
| Duke Energy Corp. | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 110.05 per share. | 05 May 2022 | 1,590 | 6,031 (0%) | 0% | 110.1 | 174,980 | Common Stock |
| Biogen Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 775 | 21,872 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 3,382 | 3,382 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 2,094 | 2,094 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Sale of securities on an exchange or to another person at price $ 450.00 per share. | 10 Jun 2021 | 1,000 | 8,501 (0%) | 0% | 450 | 450,000 | Common Stock |
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 881 | 9,501 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 397.09 per share. | 25 May 2021 | 385 | 8,620 (0%) | 0% | 397.1 | 152,880 | Common Stock |
| Duke Energy Corp. | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 100.57 per share. | 06 May 2021 | 1,591 | 4,441 (0%) | 0% | 100.6 | 160,000 | Common Stock |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.40 per share. | 05 Apr 2021 | 7,500 | 12,910 (0%) | 0% | 6.4 | 48,000 | Common Stock |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 7,500 | 9,088 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Sale of securities on an exchange or to another person at price $ 82.35 per share. | 05 Apr 2021 | 4,686 | 6,210 (0%) | 0% | 82.3 | 385,892 | Common Stock |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Sale of securities on an exchange or to another person at price $ 81.49 per share. | 05 Apr 2021 | 2,014 | 10,896 (0%) | 0% | 81.5 | 164,121 | Common Stock |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Sale of securities on an exchange or to another person at price $ 82.99 per share. | 05 Apr 2021 | 800 | 5,410 (0%) | 0% | 83.0 | 66,392 | Common Stock |
| Biogen Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 890 | 21,097 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2020 | 963 | 9,005 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 354.41 per share. | 26 May 2020 | 519 | 8,042 (0%) | 0% | 354.4 | 183,939 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges